ꯍꯥꯏ-ꯀ꯭ꯕꯥꯂꯤꯇꯤ ꯑꯣꯖꯟ ꯂꯣꯁ ꯄꯦꯄꯇꯤꯛ ꯀꯦꯒ꯭ꯔꯤꯂꯤꯟꯇꯤꯗ

ꯍꯥꯏ-ꯀ꯭ꯕꯥꯂꯤꯇꯤ ꯑꯣꯖꯟ ꯂꯣꯁ ꯄꯦꯄꯇꯤꯛ ꯀꯦꯒ꯭ꯔꯤꯂꯤꯟꯇꯤꯗ

ꯄꯣꯠꯊꯣꯛꯀꯤ ꯃꯃꯤꯡ: ꯀꯦꯒ꯭ꯔꯤꯂꯤꯟꯇꯤꯗ ꯃꯤꯅꯤꯃꯝ ꯑꯣꯔꯗꯔ: 10 ꯋꯥꯏꯜ/ꯕꯣꯛꯁ, ꯄꯦꯃꯦꯟꯇ: ꯇꯤ/ꯇꯤ, ꯕꯦꯉ꯭ꯛ ꯇ꯭ꯔꯥꯟꯁꯐꯔ, ꯕꯦꯉ꯭ꯛ ꯇ꯭ꯔꯥꯟꯁꯐꯔ, ꯑꯦꯂꯤꯕꯥꯕꯥ, ꯑꯦꯂꯤꯕꯦꯕꯥ, ꯋꯤꯆꯥꯠ,ꯋꯥꯏꯖ ꯔꯦꯒꯨꯂꯥꯔ ꯄꯦꯀꯤꯡ: 5mg/vial, 10mg/val, 15mg/val/val, 20mg/val, 30mg/val, 30mg/valing } ꯑꯦꯅꯥꯂꯣꯒ ꯑꯁꯤꯅꯥ ꯃꯁꯤꯒꯤ...
ꯏꯅꯛꯕꯥꯔꯤ ꯊꯥꯕꯤꯌꯨ
ꯋꯥꯔꯣꯜ
Cagrilintide

ꯄꯣꯠꯊꯣꯛ

ꯄꯣꯠꯊꯣꯛꯀꯤ ꯃꯃꯤꯡ: ꯀꯦꯒ꯭ꯔꯤꯂꯤꯟꯇꯤꯗ

ꯃꯤꯅꯤꯃꯝ ꯑꯣꯔꯗꯔ: ꯱꯰ ꯋꯥꯏꯜ/ꯕꯣꯛꯁ, ꯳.
ꯄꯦꯃꯦꯟꯇ: ꯇꯤ/ꯇꯤ, ꯀ꯭ꯔꯦꯗꯤꯠ ꯀꯥꯔꯗ, ꯕꯦꯉ꯭ꯛ ꯇ꯭ꯔꯥꯟꯁꯐꯔ, ꯑꯂꯤꯕꯥꯕꯥ, ꯑꯂꯤꯄꯦ, ꯋꯦꯕꯆꯥꯠ,ꯋꯥꯏꯖ
ꯆꯥꯡ ꯅꯥꯏꯅꯥ ꯄꯦꯀꯤꯡ ꯇꯧꯕꯥ: 5mg/vial, 10mg/vial, 15mg/vial, 20mg/vial, 30mg/val

ꯐꯥꯔꯃꯥꯀꯣꯂꯣꯖꯤꯀꯦꯜ ꯃꯦꯀꯥꯅꯤꯖꯝ:

ꯀꯦꯒ꯭ꯔꯤꯂꯤꯟꯇꯤꯗ ꯑꯁꯤ ꯃꯈꯥꯗꯥ ꯄꯤꯔꯤꯕꯥ ꯂꯝꯕꯤꯁꯤꯡ ꯑꯁꯤꯒꯤ ꯈꯨꯠꯊꯥꯡꯗꯥ ꯃꯁꯤꯒꯤ ꯏꯐꯦꯛꯇꯁꯤꯡ ꯑꯁꯤ ꯄꯤꯔꯤꯕꯥ ꯑꯦꯃꯤꯂꯤꯟ ꯑꯦꯅꯥꯂꯣꯒ ꯑꯃꯥ ꯁꯥꯡꯅꯥ{0}}ꯑꯦꯛꯇꯤꯡ ꯑꯦꯃꯤꯂꯤꯟ ꯑꯦꯅꯥꯂꯣꯒ ꯑꯃꯅꯤ:

1.ꯑꯦꯄꯦꯇꯥꯏꯠ ꯔꯤꯒꯨꯂꯦꯠ ꯇꯧꯕꯥ: ꯒ꯭ꯌꯥꯁꯀꯤ ꯏꯝꯄꯣꯔꯠ ꯇꯧꯕꯥ ꯊꯦꯡꯊꯍꯅꯕꯥ, ꯁꯦꯇꯤꯐꯥꯏ ꯍꯦꯅꯒꯠꯍꯅꯕꯥ ꯑꯃꯁꯨꯡ ꯆꯤꯟꯖꯥꯛ ꯆꯥꯕꯥ ꯍꯟꯊꯍꯅꯕꯥ꯫

2.ꯁꯦꯟꯠꯔꯦꯜ ꯑꯣꯖꯟ ꯍꯟꯊꯍꯅꯕꯥ: ꯍꯉ꯭ꯒꯔ ꯁꯤꯒꯅꯦꯂꯁꯤꯡ ꯊꯤꯡꯅꯕꯥ ꯍꯥꯏꯄꯣꯊꯦꯂꯥꯃꯥꯏꯛ ꯐꯤꯗꯤꯡ ꯁꯦꯟꯇꯔꯗꯥ ꯊꯕꯛ ꯇꯧꯏ꯫

3.ꯁꯤꯅꯦꯔꯖꯤꯁ꯭ꯇꯤꯛ ꯏꯐꯦꯛꯇ (ꯀꯝꯄꯥꯎꯟꯗ ꯄ꯭ꯔꯦꯄꯥꯔꯦꯁꯅꯁꯤꯡꯒꯨꯝꯕꯥ) : GLP-1 ꯔꯤꯁꯦꯞꯇꯔ ꯑꯦꯒꯣꯅꯤꯁ꯭ꯇꯁꯤꯡ (ꯁꯦꯃꯥꯒ꯭ꯂꯨꯇꯥꯏꯗꯒꯨꯝꯕꯥ)ꯒꯥ ꯄꯨꯟꯅꯥ ꯆꯠꯃꯤꯟꯅꯔꯀꯄꯥ ꯃꯇꯃꯗꯥ, ꯃꯁꯤꯅꯥ ꯗ꯭ꯌꯨꯑꯦꯜ ꯔꯤꯒꯨꯂꯦꯠ ꯇꯧꯕꯥ ꯉꯝꯃꯤ ꯑꯃꯁꯨꯡ ꯑꯔꯨꯝꯕꯥ ꯍꯟꯊꯍꯅꯕꯥ ꯑꯃꯁꯨꯡ ꯍꯥꯏꯄꯣꯒ꯭ꯂꯥꯏꯁꯦꯃꯤꯛ ꯏꯐꯦꯛꯇꯁꯤꯡ ꯍꯦꯅꯒꯠꯍꯅꯕꯥ ꯉꯝꯃꯤ꯫

ꯄꯣꯠꯊꯣꯛ ꯑꯁꯤꯒꯤ ꯀꯥꯟꯅꯕꯥ .

ꯄꯣꯇꯦꯟꯇ ꯍꯥꯏꯄꯣꯒ꯭ꯂꯥꯏꯁꯦꯃꯤꯛ ꯏꯐꯦꯛꯇ: ꯀ꯭ꯂꯤꯅꯤꯀꯦꯜ ꯃꯦꯅꯤꯐꯦꯁ꯭ꯇꯦꯁꯅꯁꯤꯡꯅꯥ HBA1C (2.0%-2.5% ꯐꯥꯎꯕꯥ)ꯗꯥ ꯆꯥꯎꯅꯥ ꯍꯟꯊꯕꯥ ꯎꯕꯥ ꯐꯪꯏ꯫

ꯑꯉꯀꯄꯥ ꯑꯔꯨꯝꯕꯥ ꯍꯟꯊꯕꯒꯤ ꯏꯐꯦꯛꯇ: ꯆꯥꯡꯆꯠꯇꯥ ꯑꯣꯏꯕꯥ ꯑꯔꯨꯝꯕꯥ ꯍꯟꯊꯕꯥ ꯑꯁꯤꯅꯥ 15%-22% (ꯍꯥꯏ-ꯗꯣꯖ ꯒ꯭ꯔꯨꯞ) ꯌꯧꯕꯥ ꯉꯝꯃꯤ꯫

ꯄꯣꯇꯦꯟꯁꯤꯑꯦꯜ ꯀꯥꯔꯗꯤꯑꯣꯚꯥꯁ꯭ꯀꯨꯂꯥꯔ ꯕꯦꯅꯤꯐꯤꯇꯁꯤꯡ: ꯄ꯭ꯔꯤꯂꯤꯃꯤꯅꯥꯔꯤ ꯁ꯭ꯇꯗꯤꯁꯤꯡꯅꯥ ꯀꯥꯔꯗꯤꯑꯣꯚꯥꯁ꯭ꯀꯨꯂꯥꯔ ꯔꯤꯁ꯭ꯛ ꯐꯦꯛꯇꯔꯁꯤꯡ ꯐꯒꯠꯍꯅꯕꯥ ꯌꯥꯏ ꯍꯥꯌꯅꯥ ꯇꯥꯛꯂꯤ꯫

CagrilintideCagrilintide

product-1024-614

ꯍꯠ ꯇꯦꯒꯁ: ꯍꯥꯏ-ꯀ꯭ꯕꯥꯂꯤꯇꯤ ꯑꯣꯖꯟ ꯂꯣꯁ ꯄꯦꯄꯇꯤꯛ ꯀꯦꯒ꯭ꯔꯤꯂꯤꯟꯇꯤꯗ, ꯆꯥꯏꯅꯥ ꯍꯥꯏ-ꯀ꯭ꯕꯥꯂꯤꯇꯤ ꯑꯣꯖꯟ ꯂꯣꯁ ꯄꯦꯄꯇꯤꯛ ꯀꯦꯒ꯭ꯔꯤꯂꯤꯟꯇꯤꯗ ꯃꯦꯟꯌꯨꯐꯦꯀꯆꯔꯔꯁꯤꯡ, ꯁꯞꯂꯥꯏꯌꯔꯁꯤꯡ, ꯐꯦꯛꯇꯔꯤ